EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

Osteosarcoma (OS) is a rare tumor of the bone occurring mainly in young adults accounting for 5% of all childhood cancers. Because of the limited therapeutic options, there has been no survival improvement for OS patients in the past 40 years. The epidermal growth factor receptor (EGFR) is highly ex...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:EMBO Mol Med
Autori principali: Linder, Markus, Glitzner, Elisabeth, Srivatsa, Sriram, Bakiri, Latifa, Matsuoka, Kazuhiko, Shahrouzi, Parastoo, Dumanic, Monika, Novoszel, Philipp, Mohr, Thomas, Langer, Oliver, Wanek, Thomas, Mitterhauser, Markus, Wagner, Erwin F, Sibilia, Maria
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2018
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6220323/
https://ncbi.nlm.nih.gov/pubmed/30361264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201809408
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi